TJ-41 Induces apoptosis and potentiates the apoptotic effects of 5-FU in breast cancer cell lines

Journal of Oncology

Volumn , Issue , 2009, Pages

  Wargovich, Michael ^a,b   Volate, Suresh ^a   Hudson, Robert ^a   Wang, Desuo ^a   Muga, Stephanie ^a  

^a South Carolina Cancer Center   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; BU ZHONG YI QI TANG; CASPASE 8 INHIBITOR; CASPASE 9 INHIBITOR; CYTOCHROME C; DNA; FLUOROURACIL; HERBACEOUS AGENT; STRESS ACTIVATED PROTEIN KINASE;

ALTERNATIVE MEDICINE; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CELL CYCLE; CELL PROLIFERATION; CHINESE MEDICINE; CONTROLLED STUDY; DNA CONTENT; DNA SYNTHESIS; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG POTENTIATION; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; FLOW CYTOMETRY; HERBAL MEDICINE; HUMAN; HUMAN CELL; WESTERN BLOTTING;

EID: 69249209733     PISSN: 16878450     EISSN: 16878469     Source Type: Journal    
DOI: 10.1155/2009/895381     Document Type: Article

References (43)

1. Ganry O., Phytoestrogen and breast cancer prevention European Journal of Cancer Prevention 2002 11 6 519 522
2. Cronin K. A., Yu B., Krapcho M., Modeling the dissemination of mammography in the United States Cancer Causes and Control 2005 16 6 701 712
3. Richardson M. A., Sanders T., Palmer J. L., Greisinger A., Singletary S. E., Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology Journal of Clinical Oncology 2000 18 2505 2514
4. Oka H., Yamamoto S., Kuroki T., Prospective study of chemoprevention of hepatocellular carcinoma with Sho- saiko-to (TJ-9) Cancer 1995 76 5 743 749
5. Sierpina V. S., Use of herbal medications before surgery Journal of the American Medical Association 2001 286 20 2543 2544
6. Wang X. Q., Takahashi T., Zhu S. J., Effect of Hochu-ekki-to (TJ-41), a Japanese Herbal Medicine, on Daily Activity in a Murine Model of Chronic Fatigue Syndrome Evidence-Based Complementary and Alternative Medicine 2004 1 203 206
7. Ito H., Shimura K., Studies on antitumor activity of traditional Chinese medicines (I) Japanese Journal of Cancer and Chemotherapy 1985 12 11 2145 2148
8. Ito H., Shimura K., Studies on antitumor activity of traditional Chinese medicines (II). Antitumor mechanism of traditional Chinese medicines Japanese Journal of Cancer and Chemotherapy 1985 12 11 2149 2154
9. Fushiki H., Kampo therapy for side effects of gynecologic carcinomatous chemotherapy Nippon Rinsho 2004 62 supplement 10 623 626
10. Kao S.-T., Yeh C.-C., Hsieh C.-C., The Chinese medicine Bu-Zhong-Yi-Qi-Tang inhibited proliferation of hepatoma cell lines by inducing apoptosis via G0/G1 arrest Life Sciences 2001 69 13 1485 1496
11. Harada M., Seta K., Ito O., Concomitant immunity against tumor development is enhanced by the oral administration of a kampo medicine, Hochu-ekki-to (TJ-41: Bu-Zhong-Yi-Qi-Tang) Immunopharmacology and Immunotoxicology 1995 17 4 687 703
12. Tokura Y., Sakurai M., Yagi H., Furukawa F., Takigawa M., Systemic administration of Hochu-ekki-to (Bu-Zhong-Yi-Qi-Tang), a Japanese-Chinese herbal medicine, maintains interferon- production by peripheral blood mononuclear cells in patients with mycosis fungoides Journal of Dermatology 1998 25 2 131 133
13. Longley D. B., Harkin D. P., Johnston P. G., 5-fluorouracil: mechanisms of action and clinical strategies Nature Reviews Cancer 2003 3 5 330 338
14. Brandi G., Schiavano G. F., Zaffaroni N., Mechanisms of action and antiproliferative properties of Brassica oleracea juice in human breast cancer cell lines Journal of Nutrition 2005 135 6 1503 1509
15. Nicoletti I., Migliorati G., Pagliacci M. C., Grignani F., Riccardi C., A rapid and simple method for measuring thymocyte apoptosis by propidium iodide staining and flow cytometry Journal of Immunological Methods 1991 139 2 271 279
16. Ludbrook J., Multiple comparison procedures updated Clinical and Experimental Pharmacology and Physiology 1998 25 12 1032 1037
17. Mansouri A., Ridgway L. D., Korapati A. L., Sustained activation of JNK/p38 MAPK pathways in response to cisplatin leads to Fas ligand induction and cell death in ovarian carcinoma cells Journal of Biological Chemistry 2003 278 19245 19256
18. Schwartsmann G., Ratain M. J., Cragg G. M., Anticancer drug discovery and development throughout the world Journal of Clinical Oncology 2002 20 47S 59S
19. Fushiki H., Kampo therapy for side effects of gynecologic carcinomatous chemotherapy Nippon Rinsho 2004 62 supplement 10 623 626
20. Osborne C. K., Steroid hormone receptors in breast cancer management Breast Cancer Research and Treatment 1998 51 3 227 238
21. Nuntanakorn P., Jiang B., Einbond L. S., Polyphenolic constituents of Actaea racemosa Journal of Natural Products 2006 69 3 314 318
22. Kang S. C., Lee C. M., Choi H., Evaluation of oriental medicinal herbs for estrogenic and antiproliferative activities Phytotherapy Research 2006 20 11 1017 1019
23. King M. L., Adler S. R., Murphy L. L., Extraction-dependent effects of American ginseng (Panax quinquefolium) on human breast cancer cell proliferation and estrogen receptor activation Integrative Cancer Therapies 2006 5 3 236 243
24. Saito M., Korsmeyer S. J., Schlesinger P. H., BAX-dependent transport of cytochrome C reconstituted in pure liposomes Nature Cell Biology 2000 2 8 553 555
25. Kaufmann S. H., Induction of endonucleolytic DNA cleavage in human acute myelogenous leukemia cells by etoposide, camptothecin, and other cytotoxic anticancer drugs: a cautionary note Cancer Research 1989 49 21 5870 5878
26. Smets L. A., Programmed cell death (apoptosis) and response to anti-cancer drugs Anti-Cancer Drugs 1994 5 1 3 9
27. Hengartner M. O., The biochemistry of apoptosis Nature 2000 407 6805 770 776
28. Jrgensmeier J. M., Xie Z., Deveraux Q., Ellerby L., Bredesen D., Reed J. C., Bax directly induces release of cytochrome c from isolated mitochondria Proceedings of the National Academy of Sciences of the United States of America 1998 95 9 4997 5002
29. Saito M., Korsmeyer S. J., Schlesinger P. H., BAX-dependent transport of cytochrome C reconstituted in pure liposomes Nature Cell Biology 2000 2 8 553 555
30. Zanke B. W., Boudreau K., Rubie E., The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat Current Biology 1996 6 5 606 613
31. Verheij M., Bose R., Lin X. H., Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis Nature 1996 380 6569 75 79
32. Chen Y.-R., Wang X., Templeton D., Davis R. J., The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and radiation. Duration of JNK activation may determine cell death and proliferation Journal of Biological Chemistry 1996 271 50 31929 31936
33. Yu R., Shtil A. A., Tan T.-H., Roninson I. B., Kong A.-N. T., Adriamycin activates c-jun N-terminal kinase in human leukemia cells: a relevance to apoptosis Cancer Letters 1996 107 1 73 81
34. Zanke B. W., Boudreau K., Rubie E., The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat Current Biology 1996 6 5 606 613
35. Verheij M., Bose R., Lin X. H., Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis Nature 1996 380 6569 75 79
36. Liu Z. G., Hsu H., Goeddel D. V., Karin M., Dissection of TNF receptor 1 effector functions: JNK activation is not linked to apoptosis while NF- B activation prevents cell death Cell 1996 87 3 565 576
37. Chew H. K., Medical management of breast cancer: today and tomorrow Cancer Biotherapy and Radiopharmaceuticals 2002 17 2 137 149
38. Guano F., Pourquier P., Tinelli S., Topoisomerase poisoning activity of novel disaccharide anthracyclines Molecular Pharmacology 1999 56 1 77 84
39. Mller I., Niethammer D., Bruchelt G., Anthracycline-derived chemotherapeutics in apoptosis and free radical cytotoxicity (review) International Journal of Molecular Medicine 1998 1 2 491 494
40. Gamen S., Anel A., Prez-Galn P., Doxorubicin treatment activates a Z-VAD-sensitive caspase, which causes m loss, caspase-9 activity, and apoptosis in Jurkat cells Experimental Cell Research 2000 258 1 223 235
41. Lu Y., Tatsuka M., Takebe H., Yagi T., Involvement of cyclin-dependent kinases in doxorubicin-induced apoptosis in human tumor cells Molecular Carcinogenesis 2000 29 1 1 7
42. Morse R., Rodgers J., Verrill M., Kendell K., Neuropsychological functioning following systemic treatment in women treated for breast cancer: a review European Journal of Cancer 2003 39 16 2288 2297
43. Martin K. R., Targeting apoptosis with dietary bioactive agents Experimental Biology and Medicine 2006 231 2 117 129